Management of diabetic neuropathy
Abstract
Diabetes mellitus is the commonest cause of neuropathy worldwide. Diabetic neuropathy (DN) develops in about 4-10% of diabetic patients after 5 years and in 15% after 20 years. Four main mechanisms have been postulated to underlie the pathogenesis of DN. Diabetic neuropathy can be divided into symmetrical and asymmetrical neuropathies. Diabetic Autonomic Neuropathy (DAN) parallels the severity of DSN, and affects primarily the cardiovascular, gastrointestinal, genitourinary and integumentary systems. The cornerstone of treatment of diabetic neuropathy is optimization of glycaemic control. Future treatments for diabetic neuropathy should address the underlying pathogenesis.
Keywords: Diabetes Mellitus; Management; Neuropathy.
References
-
- Bosch EP, Smith BE. Disorders of the Peripheral Nerve. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in Clinical Practice Third Edition. Oxford: Butterworth-Heinemann; 2000. pp. 2045–130.
-
- Thomas PK. Classification, differential diagnosis, and staging of diabetic neuropathy. Diabetes. 1997;46(Suppl 2):S54–S57. - PubMed
-
- Anand P. Neurotrophins and peripheral neuropathy. Phil Trans R Soc London. 1996;351:449–54. - PubMed
-
- Dyck PJ, Giannini C. Pathologic alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol. 1997;55:1181–93. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources